Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract

Guangzhen Hu; Jessica L. Phillips; Surendra Dasari; Hailey K. Jacobs; Rebecca A. Luchtel; Naoki Oishi; Tanya Hundal; Nada H. Ahmed; Akira Satou; Alan L. Epstein; N. Nora Bennani; Grzegorz S. Nowakowski; Joseph A. Murray; Andrew L. Feldman

doi:10.1038/s41375-019-0678-3

Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract

Guangzhen Hu, Jessica L. Phillips, Surendra Dasari, Hailey K. Jacobs, Rebecca A. Luchtel, Naoki Oishi, Tanya Hundal, Nada H. Ahmed, Akira Satou, Alan L. Epstein, N. Nora Bennani, Grzegorz S. Nowakowski, Joseph A. Murray, Andrew L. Feldman^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1467-1471
Number of pages	5
Journal	Leukemia
Volume	34
Issue number	5
DOIs	https://doi.org/10.1038/s41375-019-0678-3
State	Published - May 1 2020
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41375-019-0678-3

Cite this

Hu, G., Phillips, J. L., Dasari, S., Jacobs, H. K., Luchtel, R. A., Oishi, N., Hundal, T., Ahmed, N. H., Satou, A., Epstein, A. L., Bennani, N. N., Nowakowski, G. S., Murray, J. A., & Feldman, A. L. (2020). Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract. Leukemia, 34(5), 1467-1471. https://doi.org/10.1038/s41375-019-0678-3

@article{7fff25cf2e474687b8600694ac4b76c0,

title = "Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract",

author = "Guangzhen Hu and Phillips, {Jessica L.} and Surendra Dasari and Jacobs, {Hailey K.} and Luchtel, {Rebecca A.} and Naoki Oishi and Tanya Hundal and Ahmed, {Nada H.} and Akira Satou and Epstein, {Alan L.} and Bennani, {N. Nora} and Nowakowski, {Grzegorz S.} and Murray, {Joseph A.} and Feldman, {Andrew L.}",

note = "Funding Information: Acknowledgements This work was supported by Award Numbers R01 CA177734 (ALF), P30 CA15083 (Mayo Clinic Cancer Center), and P50 CA97274 (University of Iowa/Mayo Clinic Lymphoma SPORE) from the National Cancer Institute; Grant number 6574-19 from the Leukemia & Lymphoma Society; the Department of Laboratory Medicine and Pathology, Mayo Clinic; the Clinomics Program of the Center for Individualized Medicine, Mayo Clinic; and the Predolin Foundation.",

year = "2020",

month = may,

day = "1",

doi = "10.1038/s41375-019-0678-3",

language = "English (US)",

volume = "34",

pages = "1467--1471",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

Hu, G, Phillips, JL, Dasari, S, Jacobs, HK, Luchtel, RA, Oishi, N, Hundal, T, Ahmed, NH, Satou, A, Epstein, AL, Bennani, NN, Nowakowski, GS, Murray, JA & Feldman, AL 2020, 'Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract', Leukemia, vol. 34, no. 5, pp. 1467-1471. https://doi.org/10.1038/s41375-019-0678-3

TY - JOUR

T1 - Targetability of STAT3-JAK2 fusions

T2 - implications for T-cell lymphoproliferative disorders of the gastrointestinal tract

AU - Hu, Guangzhen

AU - Phillips, Jessica L.

AU - Dasari, Surendra

AU - Jacobs, Hailey K.

AU - Luchtel, Rebecca A.

AU - Oishi, Naoki

AU - Hundal, Tanya

AU - Ahmed, Nada H.

AU - Satou, Akira

AU - Epstein, Alan L.

AU - Bennani, N. Nora

AU - Nowakowski, Grzegorz S.

AU - Murray, Joseph A.

AU - Feldman, Andrew L.

N1 - Funding Information: Acknowledgements This work was supported by Award Numbers R01 CA177734 (ALF), P30 CA15083 (Mayo Clinic Cancer Center), and P50 CA97274 (University of Iowa/Mayo Clinic Lymphoma SPORE) from the National Cancer Institute; Grant number 6574-19 from the Leukemia & Lymphoma Society; the Department of Laboratory Medicine and Pathology, Mayo Clinic; the Clinomics Program of the Center for Individualized Medicine, Mayo Clinic; and the Predolin Foundation.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85076829925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076829925&partnerID=8YFLogxK

U2 - 10.1038/s41375-019-0678-3

DO - 10.1038/s41375-019-0678-3

M3 - Article

C2 - 31836854

AN - SCOPUS:85076829925

VL - 34

SP - 1467

EP - 1471

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -

Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this